33rd Pharmacovigilance 2023
Mumbai, India, 2023-Sep-23 — /EPR Network/ — Our conference provides the foundation for strong strategic planning and practical decision-making in your pharmacovigilance programs. This year’s [read full press release…]
drug development
Creative BioMart Provides Game-changing Microbial Solutions for Drug Development
Shirley, NY, 2023-Feb-02 — /EPR Network/ — Creative BioMart Microbe, a sub-brand of Creative BioMart that provides microbiological services and products to multi-industry customers, now [read full press release…]
27th Pharmacovigilance 2022
London, UK, 2022-Jan-10 — /EPR Network/ — “Latest developments in pharmacovigilance, drug safety and risk management” 23rd & 24th February 2022, Pestana Chelsea Bridge Hotel [read full press release…]
BOC Sciences Promotes Drug Development by Pharmaceutical Impurity Identification
Shirley, NY, 2022-Jan-06 — /EPR Network/ — BOC Sciences, a New York-based company with a long-term commitment to providing pharmaceutical discovery services and raw materials, recently introduces pharmaceutical [read full press release…]
Multiplex Assays Market – Use of Multiplex Assays in Companion Diagnostics
Pune, India, 2020-Sep-24 — /EPR Network/ — According to a new market research report “Multiplex Assays Market by Product (Consumables, Instruments), Type (Nucleic Acid, Protein, Cell), Technology [read full press release…]
Multiplex Assays Market to Reach $3.35 Billion in 2023 | Use of Multiplex Assays in Companion Diagnostics
Pune, India, 2020-Sep-04 — /EPR Network/ — According to a new market research report “Multiplex Assays Market by Product (Consumables, Instruments), Type (Nucleic Acid, Protein, Cell), Technology [read full press release…]
A New Scientific Breakthrough for the Corona-Virus (COVID-19) Disease
Haifa, Israel, 2020-Aug-04 — /EPR Network/ — Summary: “People that are trying to build their businesses should try to understand how the coronavirus pandemic is [read full press release…]
Growing Demand of Multiplex Assays in Companion Diagnostic | Business Growth Worth $3.35 Billion by 2023
Pune, India, 2020-Jul-15 — /EPR Network/ — According to a new market research report “Multiplex Assays Market by Product (Consumables, Instruments), Type (Nucleic Acid, Protein, Cell), Technology [read full press release…]
Tagraxofusp – API Insight, 2018
Tagraxofusp, sold under the brand name of Elzonris, is an Interleukin 3 (IL-3) conjugated truncated diphtheria toxin. It is composed of catalytic and translocation domains [read full press release…]
Dasatinib – Drug Insight and Forecast, 2018
CITY, Country, 2019-Jul-17 — /EPR Network/ — Dasatinib (Sprycel) medicines are generally used to treat people with chronic myeloid leukemia and people with acute lymphoblastic [read full press release…]
Cabozantinib- API Insight, 2018
CITY, Country, 2019-Jul-17 — /EPR Network/ — Cabozantinib, sold under the brand name of Cabometyx and Cometriq, is used for the treatment of medullary thyroid [read full press release…]
Myelodysplastic Syndromes (MDS) – Epidemiology Insights (2016-2028)
CITY, Country, 2019-Jul-17 — /EPR Network/ — Myelodysplastic syndromes (MDS) can be described as a group of hematologic malignancies, that occurr due to abnormality in [read full press release…]
Want to know positive clinical results of Akt/Protein Kinase B (PKB) Inhibitors?
CITY, Country, 2019-Jul-17 — /EPR Network/ — According to a new research report “Akt/Protein Kinase B (PKB) Inhibitors – Pipeline Analysis 2018, Clinical Trials & Results, Patents, [read full press release…]
Whole Slide Imaging Systems Market: Surged Investments in Drug Development Endeavors Augments Growth
Albany, US, 2019-Mar-13 — /EPR Network/ —To achieve optimum clinical outcome and attain significant insights on disease prognosis and its subsequent therapeutic approach, adoption of [read full press release…]
Vascular BioSciences Awarded $2 Million Phase II STTR Grant From NHLBI to Develop CAR Peptide as a Targeted Therapy for Pulmonary Hypertension
Durham, North Carolina, 2018-Oct-22 — /EPR Network/ — Vascular BioSciences (VBS) is proud to report the award of Phase II STTR grant funding from the [read full press release…]
Inflammatory Skin Diseases Drug Development Pipeline Studied and Analyzed in a New Healthcare Report
Albany, US, 2018-Jun-26 — /EPR Network/ —To render medical attention in critical inflammatory skin diseases such as acne vulgaris, rosacea and chronic urticaria, pharmaceutical companies [read full press release…]
Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Insight, 2018
Albany, US, 2018-May-09 — /EPR Network/ — A fresh report has been added to the wide database of Market Research Hub (MRH). The research study is [read full press release…]
Influenza A Viral Infections Drug Development Pipeline Review and Insight, 2018
Albany, US, 2018-May-09 — /EPR Network/ — A fresh report has been added to the wide database of Market Research Hub (MRH). The research study is [read full press release…]
Cognitive Impairment Disorders Drug Development Pipeline Insight, 2018
Albany, US, 2018-Apr-26 — /EPR Network/ — A comprehensive study, with a prime focus on Pharmaceutical industry has been publicized to the vast archive of Market [read full press release…]
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2023 – Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market
Albany, US, 2017-Aug-08 — /EPR Network/ — Colorectal Cancer (CRC) is the most common cancer and the leading cause of cancer-related mortality globally. There were [read full press release…]
